The optimistic scenario assumes: Higher weight-loss efficacy, based on emerging data from trials of AOMs Expanded access to the drug, driving higher uptake assumptions Higher persistency, driven by reduced costs and oral forms of the drug and fewer side effects Lower weight regain after stopping the drug Higher non-weight-loss-related mortality impacts The pessimistic scenario, conversely, considers lower efficacy, lower uptake assumptions, higher and quicker weight regain, and lower non-weight-loss-related mortality impacts
This dual mechanism distinguishes tirzepatide from single-pathway GLP-1 medications, allowing it to influence appetite regulation through two complementary biological channels simultaneously
Obesity and lipid stress inhibit carnitine acetyltransferase activity
As a result, many patients are prescribed a GLP-1 and told to eat healthier and move more, but without more specific guidance, structured coaching, or follow-up
It helps alleviate physical symptoms like bloating, stomach pain, and indigestion, with the added benefit of also improving mental well-being
Use a separate 3 mL or 5 mL syringe for measuring bacteriostatic water